OUR BOARD OF DIRECTORS
Trusted industry professionals that help guide the strategic vision of our company
Daniel Spasic, M.Sc
Chairman of the Board
Daniel is a seasoned life science executive with more than 20 years of experience from the industry in clinical- and regulatory development. Daniel joined Pharmacia & Upjohn in 1995, worked with clinical drug development in Sweden and Italy in areas of CNS and Oncology. He is the founder and owner of TFS International. He grew and managed TFS International’s Clinical Contract Research Operations to a $100 million business in 20 countries and employing 800+ professionals. He sold 60% of his holding in TFS to Ratos AB in 2015.
Financial and Business Advisor
Jan serves as the CEO of Briban Invest AB, Chairman of the Board in Nok 9 and is member of the Board of Directors in Trianon AB, Studsvik AB, Netinsight AB, Anbace AB, Eurocorp AB and Trialbee AB. He served as a Director of Arcam AB since 2011 and Probi AB from 2009 to April 2010. Jan served as the President of AudioDev AB, and has also served as the Chairman of Audiodev AB since April 26, 2006 and as its Group Chief Executive until May 6, 2003. He holds a Bachelor of Business Administration from the University of Lund.
Health Care Advisor
Newton has over 20 years of experience investing in the European and US healthcare industries. He was a senior healthcare adviser for Warburg Pincus, a leading global private equity firm. Newton has been an investor and board member in successful companies including Nycomed Pharmaceuticals, Phadia, Grohe and Trinity Pharmaceuticals. Prior to Warburg Pincus, Newton was a partner at Avista Capital, a healthcare focused investment group, and a Managing Director in the private equity division of Credit Suisse.
Lars Birgerson, MD
Lars amassed more than 25 years of biopharmaceutical industry experience in senior positions, having held leading positions with companies such as Bristol-Myers Squibb, Genentech, Roche, and Pharmacia (now Pfizer). His work has focused primarily in Medical Affairs, where he has built U.S. and global organizations. He has deep experience on issues related to clinical development, product/indication launch and real-world evidence. Since 2016 Lars is providing senior advisory services to the Life Science Industry through his company The Birgerson Group.
Patrik Sobocki, M.Sc., Ph.D.
Digital Health Investment Advisor
Patrik is a seasoned life science executive and venture investor with almost 20 years' experience including two start-up journeys in HealthTech, international leadership roles both in R&D and Commercial sides.
Today, Patrik is leading venture investments in HealthTech with Industrifonden. Prior to joining Industrifonden, Patrik was CEO of a HealthTech start-up (Pygargus) which was successfully exited to IMS Health in 2013. He stayed with IMS for three years with leadership positions in Europe, Africa and Asia.
Anders TullgrenHealth Care Business Advisor
Anders is a senior biopharmaceutical executive with over 30 years of global pharmaceutical and biotech experience and has held executive positions in both the US and Europe. During his career, he has successfully built and aligned commercial, access, pricing, regulatory and clinical plans for teams across the globe. With experience in oncology, cardiovascular, and CNS, Anders currently serves as the Chairman of Xbrane Biopharma, Sweden and is a board member of Symphogen, Denmark, Branding Science Ltd , Uk., and Biotoscana Investments SA.
Jonas has co-founded Trialbee, providing a scalable & engaging patient-centered data platform for modern research collecting data and connecting communication amongst stakeholders. Jonas was instrumental in establishing the company on the market with several top 10 Big Pharma companies as customers and has managed the Trialbee products, leading sales and marketing. Jonas was previously a Product Manager at Sony Ericsson Mobile Communications, where he managed the lifecycle of several successful phones.